Stuart has an unapologetic passion for Cell therapies. Educated with a Ph.D from Cambridge University in Neuroscience, Stuart has investigated several neurodegenerative disorders and evolved his interests from discovery research to interventional cell and gene therapies. Stuart has spent the last 10 years employing hollow-fiber bioreactors to unmet medical needs from the culture of MSCs, to exosome and viral vectors generation and also suspension cells expansion
Also Speaking
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023